Copd, Empowerment, Empowerment, Patient, Self Efficacy
Conditions
Keywords
telenursing, empowerment, Pulmonary Disease, Chronic Obstructive
Brief summary
The aim of this study is to evaluate the effect of telenursing interventions based on the empowerment model in empowering patients with COPD.
Detailed description
Patient empowerment is gaining importance and popularity day by day as it can be sustained through telehealth applications. The importance of using communication technologies in providing health care services has become more evident during the COVID-19 pandemic. When integrated into healthcare, technology-centric services provide continuous and easily accessible health data for patients and help facilitate self-monitoring. With tele-nursing, COPD patients can be strengthened in health literacy by teaching them how to access accurate and reliable resources. Through tele-nursing, online support groups and forums can be created among COPD patients so that patients can share their experiences with each other. In this way, social support is provided to patients who have to remain in social isolation due to their illness.
Interventions
OTHERTelenursing Interventions
Patient follow-up with phone calls and text messages
Sponsors
The Scientific and Technological Research Council of Turkey
Zahide Aksoy
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Outcomes Assessor)
Masking description
In order to prevent selection bias in the study, the assignment to the experimental and control groups will be made on a computer by a person who is unfamiliar with the research process. Individuals included in the study will not be told whether they are in the experimental or control group. The analysis of the data will be done by a statistics expert who is outside the research process.
Intervention model description
Two groups with experimental and control groups
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Having a confirmed COPD diagnosis for at least one year * being literate, * Having the cognitive and mental competence to answer questions, * Being able to use a mobile phone, * Disease symptoms are at a level that does not interfere with communication, * Being in COPD Stage 2 and Stage 3 according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD: Global Initiative for Chronic Obstructive Lung Disease) criteria (30% ≤ FEV1 \<80% (of expected)),
Exclusion criteria
* The disease is in the acute exacerbation period, * Dyspnea is at a level that prevents cooperation, * Having sensory loss regarding vision, hearing and speech, * Refusal to sign informed consent forms * It is the refusal of the research to complete the data collection tools.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| COPD Empowerment Scale | Pre-test, Post-test (3rd month), Follow-up Test (6th month) | A 31-item scale that evaluates the impact of interventions on individuals with COPD. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| COPD Assesment Test | Pre-test, Post-test (3rd month), Follow-up Test (6th month) | It is an eight-item test that measures the effects of COPD and deterioration in health status. CAT assessment test score; 0-10 is low 11-20 is considered medium effective, 21-30 is considered highly effective, and 31-40 is considered very high effective. |
| Number of hospital admissions due to COPD exacerbation | Pre-test, Post-test (3rd month), Follow-up Test (6th month) | The number of hospital admissions due to COPD exacerbation in the experimental group will decrease. |
| Number of hospitalizations due to COPD exacerbation | Pre-test, Post-test (3rd month), Follow-up Test (6th month) | The number of hospitalizations due to COPD exacerbation in the experimental group will decrease. |
| Lung Function Test | Pre-test, Post-test (3rd month), Follow-up Test (6th month) | A spirometri test that evaluates lung capacity. FEV1 values will increase after the intervention. |
| Modified Medical Research Council | Pre-test, Post-test (3rd month), Follow-up Test (6th month) | A brief 5-item scale describing dyspnea. Scores between 0 and 1 are considered mild, and scores of 2 and above are considered moderate to severe dyspnea. |
| Inhaler Device Use Skill Scale | Pre-test, Post-test (3rd month), Follow-up Test (6th month) | An observational test that measures inhaler device usage skill, with 10 usage steps explained. 1 point for correct use of each item; Incomplete or incorrect use is given 0 points. |
| Modified Barthel Index | Pre-test, Post-test (3rd month), Follow-up Test (6th month) | A scale that evaluates physical competence and independence in daily living activities. It evaluates 0-15 points with 10 items. On this scale, where the possible score varies between 0 and 100, the higher the score, the more independent the patient is from other people. |
Countries
Turkey (Türkiye)
Outcome results
None listed